The goal of the developing, interdisciplinary discipline of synthetic biology is to simplify and improve the design, development, and optimization of biological systems. The functionality of biological systems is necessary for advances in synthetic biology. In addition, despite biology's lack of predictability, a rise in the creation of tiny molecules utilising synthetic biology techniques boosts the market. The market for synthetic biology products rises as societal perceptions of synthetic biology change. As a result, major market players are investing in strategic development through activities like acquisition, collaboration, etc. in order to grow their companies and meet demand.
The Global Synthetic Biology Market is estimated to be valued at US$ 13.9 billion in 2022 and is expected to exhibit a CAGR of 28.0% during the forecast period (2022-2030).
Prominent Players in the Synthetic Biology Industry:
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. since 1956 offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. It has headquarters based in Waltham, Massachusetts. Thermo Fisher Scientific, the world leader in serving science, in the month of December. 2022 announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Applied Biosystems TaqPath Monkeypox/Orthopox Virus DNA Kit.
Synbio Technologies
Founded in 2013 by a group of passionate synthetic biologists with decades of industry experience and a proven track record of delivering cost-effective DNA solutions. Synbio Technologies was incorporated with a single mission in mind: to empower scientific discoveries by providing access to the world’s most advanced synthetic biology tools and services. It has headquarters situated in NJ, USA.
Merck KGaA.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Agilent Technologies, Inc.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Amyris
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. In October, 2022 Amyris, Inc. a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, announced a partnership with World Wildlife Fund (WWF), one of the world's leading conservation organizations, to support WWF's efforts to improve ocean health and reduce the impact of fishing on shark populations.